| 1 |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 801-810.
|
| 2 |
Bauer M, Gerlach H, Vogelmann T, et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019-results from a systematic review and meta-analysis[J]. Crit Care, 2020, 24 (1): 239.
|
| 3 |
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47 (11): 1181-1247.
|
| 4 |
Dewitte A, Labat A, Duvignaud PA, et al. High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study[J]. Ann Intensive Care, 2021, 11 (1): 139.
|
| 5 |
Lee GT, Hwang SY, Jo IJ, et al. Associations between mean arterial pressure and 28-day mortality according to the presence of hypertension or previous blood pressure level in critically ill sepsis patients [J]. J Thorac Dis, 2019, 11 (5): 1980-1988.
|
| 6 |
Pan P, Liu DW, Su LX, et al. Role of combining peripheral with sublingual perfusion on evaluating microcirculation and predicting prognosis in patients with septic shock[J]. Chin Med J (Engl), 2018, 131 (10): 1158-1166.
|
| 7 |
常泽楠，温仕宏，张义楠，等.脓毒症中内皮细胞高通透性的机制研究进展[J/CD].中华危重症医学杂志（电子版），2022，15（4）：337-342.
|
| 8 |
Kazune S, Caica A, Luksevics E, et al. Impact of increased mean arterial pressure on skin microcirculatory oxygenation in vasopressor-requiring septic patients: an interventional study[J]. Ann Intensive Care, 2019, 9 (1): 97.
|
| 9 |
沈延飞，蔡国龙.脓毒症相关微循环障碍的研究进展[J/CD].中华重症医学电子杂志（网络版），2020，6（2）：160-164.
|
| 10 |
Massey MJ, Hou PC, Filbin M, et al. Microcirculatory perfusion disturbances in septic shock: results from the ProCESS trial[J]. Crit Care, 2018, 22 (1): 308.
|
| 11 |
Dumas G, Lavillegrand JR, Joffre J, et al. Mottling score is a strong predictor of 14-day mortality in septic patients whatever vasopressor doses and other tissue perfusion parameters[J]. Crit Care, 2019, 23 (1): 211.
|
| 12 |
Santos DMD, Quintans JSS, Quintans-Junior LJ, et al. Association between peripheral perfusion, microcirculation and mortality in sepsis: a systematic review [J]. Braz J Anesthesiol, 2019, 69 (6): 605-621.
|
| 13 |
Xu JY, Ma SQ, Pan C, et al. A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: a prospective open label study[J]. Crit Care, 2015, 19 (1): 130.
|
| 14 |
吕立文，唐宇涛，潘春熹，等.高/低目标血压与老年脓毒症休克患者28d和90d病死率的关系[J].医学临床研究，2018，35（4）：632-634.
|
| 15 |
Dubin A, Pozo MO, Casabella CA, et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study[J]. Crit Care, 2009, 13 (3): R92.
|
| 16 |
Pan J, Peng M, Liao C, Hu X, et al. Relative efficacy and safety of early lactate clearance-guided therapy resuscitation in patients with sepsis: a meta-analysis[J]. Medicine (Baltimore), 2019, 98 (8): e14453.
|
| 17 |
王义，田家豪，杨雪峰，等.乳酸浓度联合乳酸清除率对新生儿脓毒性休克预后的预测价值[J].中华儿科杂志，2021，59（6）：489-494.
|
| 18 |
廖继旸，袁金霞，韩云，等.成人乳酸清除率指导脓毒症复苏治疗价值的Meta分析[J].解放军医学杂志，2018，43（9）：761-768.
|
| 19 |
张雪.乳酸清除率评估严重脓毒症及脓毒性休克预后的价值[J].医学信息，2020，33（16）：104-106.
|
| 20 |
Lokhandwala S, Andersen LW, Nair S, et al. Absolute lactate value vs relative reduction as a predictor of mortality in severe sepsis and septic shock [J]. Crit Care, 2017 (37): 179-184.
|
| 21 |
郝翠平，胡庆河，朱丽娜，等.血乳酸和降钙素原与病情严重程度评分对脓毒性休克患者短期预后的联合预测价值[J].中华危重病急救医学，2021，33（3）：281-285.
|
| 22 |
倪银，叶珺，王金柱，等.影响脓毒症预后因素的多元Cox回归模型分析[J].浙江医学，2017，39（9）：716-719.
|
| 23 |
吴飞，郑瑞强，陈齐红.脓毒性休克初始液体复苏：该如何选择？[J/CD].中华危重症医学杂志（电子版），2021，14（3）：244-247.
|